The generics industry: unlocking new growth drivers

The generics industry: unlocking new growth drivers

For the first time, generic antibiotics meeting EU-GMP standards are being produced in Vietnam.
Livzon subsidiary seeks control of Imexpharm

Livzon subsidiary seeks control of Imexpharm

A subsidiary of China’s Livzon Pharmaceutical Group has registered a tender offer to acquire nearly 78 per cent of Imexpharm Corporation.
Imexpharm named Vietnam’s best place to work in pharmaceutical industry

Imexpharm named Vietnam’s best place to work in pharmaceutical industry

Imexpharm has been named the #1 Best Place to Work in Vietnam 2025 in the pharmaceutical, medical devices, and healthcare sector category.
Imexpharm’s EBITDA margin rises to 22.3 per cent driven by cost management and growth

Imexpharm’s EBITDA margin rises to 22.3 per cent driven by cost management and growth

In September 2025, Imexpharm’s profit before tax surged by 101 per cent, while EBITDA increased by 48 per cent.
Vietnam’s pharma sector advancing with focus on ESG and innovation

Vietnam’s pharma sector advancing with focus on ESG and innovation

Vietnam’s pharmaceutical sector is advancing through innovation, regulation, and sustainability to help build a stronger national healthcare system.
Imexpharm sees strong first half growth with $47 million in revenue

Imexpharm sees strong first half growth with $47 million in revenue

Imexpharm has reported strong first half results for 2025, with net revenue up 22 per cent on-year.
China's Livzon to acquire 65 per cent of pharmaceutical firm Imexpharm

China's Livzon to acquire 65 per cent of pharmaceutical firm Imexpharm

China's Livzon Pharmaceutical Group Inc. will spend VND5.73 trillion ($221 million) to acquire almost 65 per cent of Imexpharm Corporation.
Imexpharm poised for strong growth driven by high-tech pharmaceuticals

Imexpharm poised for strong growth driven by high-tech pharmaceuticals

Imexpharm is pioneering the development of high-tech, high-value pharmaceuticals. ​​​​​​​
Imexpharm announces 2025 growth targets

Imexpharm announces 2025 growth targets

Imexpharm has approved its 2025 growth plan, targeting total revenue of VND2.98 trillion
Green growth paves sustainable path for pharmaceutical industry

Green growth paves sustainable path for pharmaceutical industry

Green growth is becoming essential for pharmaceutical companies in the face of increasingly severe climate change.
Vietnam accelerates in high-tech pharmaceutical race

Vietnam accelerates in high-tech pharmaceutical race

Vietnamese pharmaceutical companies are gunning for growth.
Imexpharm announces third quarter results

Imexpharm announces third quarter results

On October 18, Imexpharm Corporation announced its third quarter results.
Imexpharm’s ambitions to enter global pharma supply chain

Imexpharm’s ambitions to enter global pharma supply chain

Imexpharm is driving significant growth by boosting research and development into high-tech pharmaceuticals.
Imexpharm part of emerging trend of innovation in pharmaceuticals

Imexpharm part of emerging trend of innovation in pharmaceuticals

Imexpharm Pharmaceutical JSC (IMP) is investing heavily in high-quality pharmaceutical production technology to meet international standards.
Imexpharm recognised at Top 50 Corporate Sustainability Awards

Imexpharm recognised at Top 50 Corporate Sustainability Awards

Imexpharm Pharmaceutical JSC was honoured at the Top 50 Corporate Sustainability Awards (CSA 2023) organised by Nhip Cau Dau Tu magazine on August 2.
1 2 3